GL1X · GenesisL1 explorer

Ligand · IFC

IFC · N-[2-methyl-5-({[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]carbonyl}amino)phenyl]isoxazole-5-carboxamide

IFC, N-[2-methyl-5-({[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]carbonyl}amino)phenyl]isoxazole-5-carboxamide (C23 H18 F3 N5 O3, 469.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…

Component
IFC
Formula
C23 H18 F3 N5 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

IFC in 2 structures; the first of them:

  • 3DZQ · Human EphA3 kinase domain in complex with inhibitor AWL-II-38.3 · IFC A1001 · binds PHE632, VAL635, ALA651, ILE652, LYS653, GLU670, ILE673, MET674 and 16 more
  • 3DZQ · Human EPHA3 kinase domain in complex with inhibitor awl-II-38.3 · IFC A1001 · binds PHE632, VAL635, ALA651, ILE652, LYS653, GLU670, ILE673, MET674 and 16 more

Residues it binds most

ILE 2, PHE 2, GLU 2, LEU 2, MET 2, TYR 2, VAL 2, ALA 2, ASP 2, HIS 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.